Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.
about
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis.Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients.Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.Translational research and application of basic biology to clinical trial development in GI cancers.Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
P2860
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Angiogenesis genotyping and cl ...... ic colorectal cancer patients.
@en
type
label
Angiogenesis genotyping and cl ...... ic colorectal cancer patients.
@en
prefLabel
Angiogenesis genotyping and cl ...... ic colorectal cancer patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Angiogenesis genotyping and cl ...... tic colorectal cancer patients
@en
P2093
Alberto Zaniboni
Alessandro Bittoni
Elena Maccaroni
Giuseppe Aprile
Kalliopi Andrikou
Marco D'Anzeo
Marina Scarpelli
Mario Scartozzi
Maristella Bianconi
Michela Del Prete
P2860
P2888
P356
10.1038/SREP25195
P407
P50
P577
2016-04-27T00:00:00Z